Evidence map›Paper›PMID 39235687›Full record

ArticleObesity surgery2024

Mini-Dose Ready-to-Use Liquid Glucagon for Post-Bariatric Hypoglycemia Treatment in Experimental and Real-World Settings.

Helen Margaret Lawler, Mary Elizabeth Patti, Matthew R Krecic, Jennifer Rowell, Adrian Dobs, Anh Nguyen, Valentina Conoscenti

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Obesity surgery, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Helen Margaret Lawler *Division of Endocrinology, Metabolism, and Diabetes, Department of Medicine, University of Colorado School of Medicine, Aurora, CO, 80045, USA. helen.lawler@cuanschutz.edu.
Mary Elizabeth Patti *Research Division, Joslin Diabetes Center, and Harvard Medical School, Boston, MA, 02215, USA.
Matthew R KrecicXeris Pharmaceuticals, Inc., Chicago, IL, 60607, USA.ORCID 0000-0002-9383-5415
Jennifer RowellDivision of Endocrinology, Metabolism, and Nutrition, Duke University School of Medicine, Durham, NC, 27710, USA.
Adrian DobsJohn Hopkins University, Baltimore, MD, 21287, USA.
Anh NguyenXeris Pharmaceuticals, Inc., Chicago, IL, 60607, USA.
Valentina ConoscentiXeris Pharmaceuticals, Inc., Chicago, IL, 60607, USA.

Funding

SPECIAL ASSAY COREP30DK036836 · NIDDK · JOSLIN DIABETES CENTER · PI JEAN E. SCHAFFER · 1986 to 2026
$50.5M
NIDDK NIH HHS P30 DK036836
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

GlucagonHypoglycemiaObesity, MorbidAdultBariatric SurgeryBlood GlucoseFemaleHumansMaleMiddle AgedPostoperative ComplicationsBlood GlucoseGlucagonGastric bypassGlucagonHyperinsulinemic hypoglycemiaPost-bariatric hypoglycemia

Identifiers

PMID39235687
PMCPMC11464590

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.